Indian equity markets opened higher on Friday ahead of the Reserve Bank of India’s Monetary Policy Committee (MPC) decision on interest rates, reflecting positive investor sentiment and broad-based buying across sectors.
The benchmark BSE Sensex rose more than 300 points in early trade to move above the 74,600 mark, while the NSE Nifty 50 crossed the 23,500 level. Market breadth remained positive, with buying interest visible across a majority of stocks during the opening session, indicating sustained investor participation.
Market participants are closely monitoring the RBI MPC meeting, with investors awaiting the central bank’s decision on interest rates as well as signals regarding the future policy outlook. Expectations surrounding the policy announcement contributed to support for equities in early trading.
According to analysts, the advance in equities ahead of the policy decision reflects expectations that the central bank may pursue an approach aimed at balancing economic growth and inflation.
The RBI’s policy statement, including guidance on interest rates, inflation projections and economic growth, is expected to influence market direction. Investors are also tracking monetary policy developments among major global central banks, making the RBI’s stance significant for Indian financial markets, the banking sector and investment flows.
During early trade, banking, financial services, pharmaceutical and healthcare stocks witnessed buying interest. Private banks and financial companies contributed to gains in the benchmark indices.
Investors also focused on companies that recently announced business updates and corporate developments, resulting in gains in several prominent stocks during the opening hours.
InterGlobe Aviation (IndiGo) announced temporary changes to its international network. The airline said certain international routes will be temporarily suspended between July and September 2026 due to weaker demand and higher operating costs on those routes. The development kept investor attention on the aviation sector and could lead to volatility in the stock.
HDFC AMC announced a temporary suspension of lump-sum investments in its Gold ETF and Gold ETF Fund of Fund schemes. The company cited prevailing market conditions and investment management-related considerations for the decision. Investors are assessing the implications of the move for future investment flows and strategy.
Aurobindo Pharma received final approval from the US Food and Drug Administration (USFDA) for the manufacture and marketing of Tofacitinib Tablets. The drug is used in the treatment of arthritis and other autoimmune diseases. The regulatory approval has drawn investor attention to the company.
Global factors have also contributed to the positive momentum in Indian markets. Investor focus in recent weeks has remained on global economic growth, inflation data and policy actions by major central banks.
